At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
International Biophysics AffloVest +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements
In Brief
A clinical study evaluating International Biophysics AffloVest, Hill-Rom The Vest, and 2 other interventions for Cystic Fibrosis and Bronchiectasis. Completed, enrolled 32 participants across 1 site.
Detailed Summary
The impact of high-frequency chest wall oscillation therapy on spirometry values (Forced Expiratory Volume, Forced Vital Capacity, Peak Expiratory Flow, Forced Expiratory Flow and Tidal Volume is investigated during use of several products and comparing to baseline values.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis, Bronchiectasis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartFeb 2018
Primary CompletionMar 2018
First PostedMay 2018
TodayJul 2026
First PostedMay 23, 2018
Enrollment StartFeb 20, 2018
Primary CompletionMar 16, 2018
TodayJul 2, 2026
Enrollment to primary: 26 daysPosted 8.1 years ago
Interventions
International Biophysics AffloVestdevice
High-frequency chest wall oscillation vest
Hill-Rom The Vestdevice
High-frequency chest wall oscillation vest
Respirtech inCouragedevice
High-frequency chest wall oscillation vest
Electromed SmartVestdevice
High-frequency chest wall oscillation vest